{"id":26592,"date":"2014-06-20T08:58:49","date_gmt":"2014-06-20T12:58:49","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=26592"},"modified":"2014-06-20T08:58:49","modified_gmt":"2014-06-20T12:58:49","slug":"is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592","title":{"rendered":"Is Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Ready To Market In The European Union?"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 06\/20\/2014 (wallstreetpr) \u2013 <b>Enanta Pharmaceuticals Inc (NASDAQ:ENTA)<\/b> scored a new high on Thursday, after the shares of the company surged by more than 4% to close at $46.14. The optimism surrounding the company could be accredited to the recent announcement stating that the European Medicines agency has validated the Marketing Authorization Applications (MAAs) for AbbVie\u2019s investigational, all-oral, interferon-free regimen.<\/p>\n<p style=\"text-align: justify;\"><b>MAAs Validated<\/b><\/p>\n<p style=\"text-align: justify;\">The validation brings the company under the accelerated assessment by the European Medicines Agency. AbbVie&#8217;s regimen is primarily meant to address the chronic genotype 1 (GT1) hepatitis C virus (HCV) infection among adult patients. The three antiviral investigational regimens acting directly for GT1 comprises of the fixed dose of ABT -450\/ritonavir and ombitasvir (ABT-267) 25 mg, as well as dasabuvir (ABT-333) 250 mg.ABT-450 is the company\u2019s primary potease inhibitor formulated through it\u2019s collaboration with AbbVie.<\/p>\n<p style=\"text-align: justify;\">The accelerated assessment is a review process undertaken by the EMA for those medicines that carry a major public interest. The same was conferred to AbbVie&#8217;s investigational HCV medicine in May 2014. The validation of the MAAs establishes that the company&#8217;s submissions are complete in all manner and thus, would be put under EMA&#8217;s centralized review. If AbbVie gets success in terms of approval by the EMA, then it could start marketing the regimen in the European Union by as early as first quarter of 2015.<\/p>\n<p style=\"text-align: justify;\"><b>Marketing Authorization In The EU<\/b><\/p>\n<div><strong>AbbVie Inc (NYSE:ABBV)<\/strong> had submitted the MAAs on May 8, 2014, which were accompanied by a large data derived from an extensive clinical program, including reports from six phase 3 studies of over 2,300 GT1 patients across 25 countries. As per the standard procedure, the review of the submitted MAAs will be carried out under the centralized licensing procedure. The finalization and approval will allow the company to market its regimen in all of the 28 states included in the European Union.<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 06\/20\/2014 (wallstreetpr) \u2013 Enanta Pharmaceuticals Inc (NASDAQ:ENTA) scored a new high on Thursday, after the shares of the company surged by more than [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":26605,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[1593,7495,5382,5383,1592],"stock_ticker":[],"class_list":["post-26592","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-abbvie-inc-nyseabbv","tag-enanta-pharmaceuticals-inc","tag-enanta-pharmaceuticals-inc-nasdaqenta","tag-nasdaqenta","tag-nyseabbv","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Is Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Ready To Market In The European Union? - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Is Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Ready To Market In The European Union? - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 06\/20\/2014 (wallstreetpr) \u2013 Enanta Pharmaceuticals Inc (NASDAQ:ENTA) scored a new high on Thursday, after the shares of the company surged by more than [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-06-20T12:58:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/ENTA.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"240\" \/>\n\t<meta property=\"og:image:height\" content=\"160\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Benjamin Roussey\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benjamin Roussey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592\"},\"author\":{\"name\":\"Benjamin Roussey\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\"},\"headline\":\"Is Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Ready To Market In The European Union?\",\"datePublished\":\"2014-06-20T12:58:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592\"},\"wordCount\":316,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/ENTA.jpg\",\"keywords\":[\"AbbVie Inc. (NYSE:ABBV)\",\"Enanta Pharmaceuticals Inc\",\"Enanta Pharmaceuticals Inc (NASDAQ:ENTA)\",\"NASDAQ:ENTA\",\"NYSE:ABBV\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592\",\"name\":\"Is Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Ready To Market In The European Union? - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/ENTA.jpg\",\"datePublished\":\"2014-06-20T12:58:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/ENTA.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/ENTA.jpg\",\"width\":240,\"height\":160},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Is Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Ready To Market In The European Union?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\",\"name\":\"Benjamin Roussey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"caption\":\"Benjamin Roussey\"},\"description\":\"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Is Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Ready To Market In The European Union? - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592","og_locale":"en_US","og_type":"article","og_title":"Is Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Ready To Market In The European Union? - Wall Street PR","og_description":"Boston, MA 06\/20\/2014 (wallstreetpr) \u2013 Enanta Pharmaceuticals Inc (NASDAQ:ENTA) scored a new high on Thursday, after the shares of the company surged by more than [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-06-20T12:58:49+00:00","og_image":[{"width":240,"height":160,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/ENTA.jpg","type":"image\/jpeg"}],"author":"Benjamin Roussey","twitter_misc":{"Written by":"Benjamin Roussey","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592"},"author":{"name":"Benjamin Roussey","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d"},"headline":"Is Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Ready To Market In The European Union?","datePublished":"2014-06-20T12:58:49+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592"},"wordCount":316,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/ENTA.jpg","keywords":["AbbVie Inc. (NYSE:ABBV)","Enanta Pharmaceuticals Inc","Enanta Pharmaceuticals Inc (NASDAQ:ENTA)","NASDAQ:ENTA","NYSE:ABBV"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592","url":"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592","name":"Is Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Ready To Market In The European Union? - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/ENTA.jpg","datePublished":"2014-06-20T12:58:49+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/ENTA.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/06\/ENTA.jpg","width":240,"height":160},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/is-enanta-pharmaceuticals-inc-nasdaqenta-ready-to-market-in-the-european-union-26592#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Is Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Ready To Market In The European Union?"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d","name":"Benjamin Roussey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","caption":"Benjamin Roussey"},"description":"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/26592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=26592"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/26592\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/26605"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=26592"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=26592"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=26592"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=26592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}